Delivery Order HT001122D0040-HT001122F0114
- This is a Delivery Order under the Medical Product Research and Development Indefinite Delivery Vehicle (IDV) awarded by the Defense Health Agency (DHA) to PPD Development LP, a global contract research organization (CRO) subsidiary of Thermo Fisher Scientific. The $516,110.95 cost-plus-fixed-fee contract supports an HIV Cohort Study, with a period of performance through October 13, 2022. The contract does not have a set-aside designation. PPD Development LP, a highly experienced federal...
- This is a firm-fixed price delivery order awarded by the Department of the Army Medical Command to PPD Development LP, a global contract research organization (CRO), in the amount of $198,044.52. The order is for labor analysis of alternatives for extremity repair in regards to vascular grafting services during the base period. This delivery order is under the Medical Product Research and Development contract vehicle. The contract has no set-aside designation. As a prime contractor, PPD has...
- This is a federal contract award to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The $151,299.72 firm fixed-price delivery order was issued under the Medical Product Research and Development Indefinite Delivery Vehicle (IDV) with the U.S. Army Medical Command (MEDCOM). The contract does not have a set-aside designation. PPD Development LP provides comprehensive clinical trial and research support services to various federal...
- This is a Firm Fixed Price Delivery Order contract awarded by the U.S. Army Medical Command (MEDCOM) to PPD Development LP, a global contract research organization (CRO) subsidiary of Thermo Fisher Scientific. The $239,945.00 contract is part of the Medical Product Research and Development Indefinite Delivery Vehicle (IDV), and covers dengue market research services. The contract has no set-aside designation and is scheduled for completion by December 6, 2016. As a CRO, PPD Development LP has...
- This is a Firm Fixed Price Delivery Order awarded by the Department of the Army Medical Command to PPD Development LP, a global contract research organization (CRO), for the development of a U.S. Army Blood Products and Components Concept of Operations (CONOPS) for Damage Control Resuscitation (DCR). The contract has a potential value of $462,762.35 and was not set aside for any specific business type. The order falls under the broader Medical Product Research and Development Indefinite Delivery...
- This is a $1,345,959.23 firm-fixed-price delivery order awarded by the U.S. Army Medical Command (MEDCOM) to PPD Development LP, a global contract research organization. The order is for FDA regulatory compliance training and is part of the parent Medical Product Research and Development indefinite delivery/indefinite quantity (IDIQ) contract. PPD Development LP is a subsidiary of Thermo Fisher Scientific and has been providing a wide range of services to federal agencies, including clinical...
- This is a $304,193.20 firm fixed-price delivery order contract awarded to PPD Development LP, a global contract research organization (CRO), by the Department of the Army Medical Command for an external assessment of the U.S. Army Medical Materiel Development Activity (USAMMDA). The contract does not have a set-aside designation. As a prime contractor, PPD has extensive experience providing clinical trial and research support services to various federal agencies, including over $500 million in...
- This is a $27,437,094.36 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract is for research and development (R&D) in the biomedical (basic research) domain, specifically in support of NIAID's Regulatory Management Center. The contract does not have a set-aside designation and was awarded on a...
- This is a delivery order under the Medical Countermeasures Clinical Studies Network contract vehicle, awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to PPD Development, LP, a global contract research organization (CRO). The $6,186,155.39 delivery order is for a H5N1 clinical study, under a cost-plus-fixed-fee contract type. PPD Development, LP has been awarded over $500 million in prime federal contracts and participated as a subcontractor on grants and...
- This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to PPD Development LP, a global contract research organization (CRO). The contract, valued at $66,339,562.95, is for the TAS::75 0885::TAS NIAID DAIT CLINICAL SITE MONITORING CENTER and has a performance period ending on February 23, 2023. PPD Development LP, a subsidiary of Thermo Fisher...
- HT001122D0040Indefinite Delivery Contract
- HT001122D0040-HT001122F0114Delivery Order
This is a delivery order contract awarded by the Defense Health Agency (DHA) to PPD Development LP, a global contract research organization (CRO). The contract, valued at $2,500.00, is for military medical research and development services. It does not have a set-aside designation. The contract is part of a larger $545 million Indefinite Delivery Vehicle (IDV) contract that PPD Development LP holds with the National Institute of Allergy and Infectious Diseases (NIAID) for comprehensive and rapid response capabilities in research programs. PPD Development LP has also been awarded other significant IDVs with federal agencies, including a $346 million multiple-award contract for NIAID's Early Phase Clinical Trial Units program and a $548 million multiple-award contract with the National Cancer Institute for cancer trials support. These IDVs position PPD Development LP as a critical partner in advancing federal medical research and development initiatives across multiple agencies and therapeutic areas.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
DHA OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT DRAFT RFP | HT001121R00040001 | Defense Health Agency | Solicitation 3/7 | 3/26/21, 4:44 PM | |
DHA OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT RFP | HT001121R00040002 | Defense Health Agency | Solicitation 4/7 | 4/12/21, 12:41 PM | |
DHA OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT | HT001121R0004 | Defense Health Agency | Award Notice 7/7 | 5/16/22, 5:41 PM | |
DHA OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT RFP AMENDMENT 0003 | HT001121R00040003 | Defense Health Agency | Solicitation 5/7 | 4/22/21, 5:00 PM | |
DHA OMNIBUS IV MILITARY MEDICAL RESEARCH AND DEVELOPMENT DRAFT RFP | HT0011-21-R-0004 | Defense Health Agency | Pre-Solicitation 1/7 | 11/13/20, 1:35 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 9/8/22 |